1. Home
  2. FONR vs OVID Comparison

FONR vs OVID Comparison

Compare FONR & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fonar Corporation

FONR

Fonar Corporation

HOLD

Current Price

$18.54

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$1.65

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FONR
OVID
Founded
1978
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.8M
117.5M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
FONR
OVID
Price
$18.54
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$3.40
AVG Volume (30 Days)
66.4K
1.3M
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.90
EPS
1.16
N/A
Revenue
$104,351,318.00
$566,000.00
Revenue This Year
N/A
$1,077.56
Revenue Next Year
N/A
N/A
P/E Ratio
$16.02
N/A
Revenue Growth
1.43
N/A
52 Week Low
$12.00
$0.24
52 Week High
$18.86
$2.01

Technical Indicators

Market Signals
Indicator
FONR
OVID
Relative Strength Index (RSI) 61.60 54.50
Support Level $18.49 $1.43
Resistance Level $18.73 $1.70
Average True Range (ATR) 0.08 0.10
MACD -0.08 0.01
Stochastic Oscillator 20.92 85.39

Price Performance

Historical Comparison
FONR
OVID

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: